AbCellera Biologics Inc. (ABCL) vs CareDx, Inc (CDNA)
A side-by-side comparison of AbCellera Biologics Inc. and CareDx, Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABCL
AbCellera Biologics Inc.
$13.78HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CDNA
CareDx, Inc
$69.85HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ABCL vs CDNA
growth of $100 · dividends reinvested · last 6yABCL -76.6% (-21.5%/yr)CDNA +7.6% (+1.2%/yr)CDNA compounded faster over this window
ABCL CDNA
ABCL vs CDNA: by the numbers
- •ABCL is the larger company ($4.21B vs $3.61B market cap).
- •CDNA is profitable (24.23% net margin) while ABCL runs a net loss (-248.83%).
- •CDNA grew revenue faster over the past five years (12.56% vs -31.78% CAGR).
Metrics side by side
Valuation
| Metric | ABCL | CDNA |
|---|---|---|
| P/E ratio | N/A | 33.72 |
| Forward P/E | N/A | 58.32 |
| P/S ratio | 63.59 | 7.89 |
| P/B ratio | 4.70 | 8.49 |
| EV / EBITDA | N/A | 209.49 |
| FCF yield | N/A | 2.35% |
Profitability
| Metric | ABCL | CDNA |
|---|---|---|
| Gross margin | 61.64% | 70.58% |
| Operating margin | -288.98% | -0.92% |
| Net margin | -248.83% | 24.23% |
| ROE | -18.38% | 26.08% |
| ROIC | -17.95% | -0.93% |
Growth (annualized)
| Metric | ABCL | CDNA |
|---|---|---|
| Revenue CAGR (5Y) | -31.78% | 12.56% |
| Total return CAGR (5Y) | -3.57% | 1.33% |
Frequently asked
- Which has grown faster, ABCL or CDNA?
- Over the past five years, CDNA grew revenue faster — ABCL at a -31.78% CAGR versus CDNA at 12.56%.
- Is ABCL or CDNA more profitable?
- CDNA runs the higher net margin — ABCL at -248.83% versus CDNA at 24.23%.
- How have ABCL and CDNA total returns compared?
- Over the past 5 years, ABCL delivered -3.57% and CDNA delivered 1.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CareDx P/E ratioAbCellera Biologics ROECareDx ROEAbCellera Biologics operating marginCareDx operating marginAbCellera Biologics revenue growthCareDx revenue growthAbCellera Biologics free cash flowCareDx free cash flow
AbCellera Biologics & CareDx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.